{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:56:41Z","timestamp":1779148601425,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["R01 EY033363-01 and P30 EY026877 Departmental Core Grant"],"award-info":[{"award-number":["R01 EY033363-01 and P30 EY026877 Departmental Core Grant"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","award":["Career Advancement Award"],"award-info":[{"award-number":["Career Advancement Award"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["P30-EY026877."],"award-info":[{"award-number":["P30-EY026877."]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>This study evaluates the second-year outcomes of an artificial intelligence-based diabetic retinopathy (DR) detection program (Stanford Teleophthalmology Autonomous Testing and Universal Screening) implemented in primary care and endocrinology clinics in Northern California. We focused on assessing improvements following the implementation of an intervention-based framework to increase artificial intelligence system gradability and patient encounters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective analysis was conducted involving diabetic patients aged 18 years and older with no prior DR diagnosis or examination in the past year. These patients presented for routine DR screening in primary care or endocrinology clinics. In its second year, the Stanford Teleophthalmology Autonomous Testing and Universal Screening program expanded to additional sites and introduced an intervention-based framework, including targeted training protocols, to enhance screening accuracy and efficiency. Our study measured artificial intelligence system gradability and tracked patient encounters over Year 2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The artificial intelligence system's gradability increased from 62.3% in Year 1 to 71.2% in Year 2, comparable with nonmydriatic gradability rates observed in clinical trials. Patient encounters increased by 21.9%, indicating expanded reach and improved accessibility. Interventions, including enhanced training protocols and camera utilization reports, effectively improved screening efficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The second-year outcomes of the Stanford Teleophthalmology Autonomous Testing and Universal Screening artificial intelligence-based DR screening program demonstrate significant improvements in image gradability by the artificial intelligence system as well as in patient encounter numbers. These findings highlight the potential of interventional methods to continually improve the outcomes of artificial intelligence-based screening programs and offer a scalable solution to the growing burden of DR. The success of Stanford Teleophthalmology Autonomous Testing and Universal Screening supports further integration and expansion of artificial intelligence-based screening in clinical practice for early detection and management of DR, improving patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004499","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:00:10Z","timestamp":1746637210000},"page":"1469-1480","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["TARGETED INTERVENTIONS LEAD TO QUALITY IMPROVEMENT IN YEAR 2 OF AN ARTIFICIAL INTELLIGENCE-BASED DIABETIC RETINOPATHY DETECTION PROGRAM IN NORTHERN CALIFORNIA"],"prefix":"10.1097","volume":"45","author":[{"given":"Karen M.","family":"Chen","sequence":"first","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy S.","family":"Zhao","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austen","family":"Knapp","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliot","family":"Dow","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"},{"name":"Retinal Consultants Medical Group, Sacramento, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Phadke","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Palo Alto, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Palo Alto, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaniksha","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Palo Alto, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Or","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana V.","family":"Do","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithvi","family":"Mruthyunjaya","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Leng","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Myung","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"},{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250723","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/ICU.0b013e32834595e8","article-title":"Challenges to establishing nationwide diabetic retinopathy screening programs","volume":"22","author":"Hazin","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-20250723","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"R3-20250723","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"R4-20250723","first-page":"e297","article-title":"Annual diabetic eye examinations in a managed care Medicaid population","volume":"21","author":"Hatef","year":"2015","journal-title":"Am J Manag Care"},{"key":"R5-20250723","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/archopht.126.12.1740","article-title":"Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050","volume":"126","author":"Saaddine","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R6-20250723","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1932296814522806","article-title":"Teleophthalmology in diabetic retinopathy","volume":"8","author":"Surendran","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"R7-20250723","doi-asserted-by":"crossref","first-page":"61","DOI":"10.47102\/annals-acadmedsg.2020459","article-title":"Teleophthalmology and its evolving role in a COVID-19 pandemic: a scoping review","volume":"50","author":"Chong","year":"2021","journal-title":"Ann Acad Med Singap"},{"key":"R8-20250723","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","article-title":"Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices","volume":"1","author":"Abr\u00e0moff","year":"2018","journal-title":"NPJ Digit Med"},{"key":"R9-20250723","doi-asserted-by":"crossref","first-page":"e2134254","DOI":"10.1001\/jamanetworkopen.2021.34254","article-title":"Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy","volume":"4","author":"Ipp","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R10-20250723","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014an extension of the modified Airlie house classification: ETDRS report number 10","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"R11-20250723","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc18-0148","article-title":"Diagnostic accuracy of a device for the automated detection of diabetic retinopathy in a primary care setting","volume":"42","author":"Verbraak","year":"2019","journal-title":"Diabetes Care"},{"key":"R12-20250723","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/aos.13613","article-title":"Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System","volume":"96","author":"van der Heijden","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R13-20250723","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1932296820906212","article-title":"Validation of automated screening for referable diabetic retinopathy with an autonomous diagnostic artificial intelligence system in a Spanish population","volume":"15","author":"Shah","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R14-20250723","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00347-021-01556-5","article-title":"Use of artificial intelligence in screening for diabetic retinopathy at a tertiary diabetes center","volume":"119","author":"Paul","year":"2022","journal-title":"Die Ophthalmologie"},{"key":"R15-20250723","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaophthalmol.2020.3190","article-title":"Cost-effectiveness of autonomous point-of-care diabetic retinopathy screening for pediatric patients with diabetes","volume":"138","author":"Wolf","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R16-20250723","doi-asserted-by":"crossref","first-page":"100330","DOI":"10.1016\/j.xops.2023.100330","article-title":"AI-human hybrid workflow enhances teleophthalmology for the detection of diabetic retinopathy","volume":"3","author":"Dow","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"R17-20250723","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2337\/dc20-1671","article-title":"The SEE study: safety, efficacy, and equity of implementing autonomous artificial intelligence for diagnosing diabetic retinopathy in youth","volume":"44","author":"Wolf","year":"2021","journal-title":"Diabetes Care"},{"key":"R18-20250723","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2337\/dc20-1877","article-title":"Multicenter, head-to-head, real-world validation study of seven automated artificial intelligence diabetic retinopathy screening systems","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"key":"R19-20250723","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2337\/dci23-0032","article-title":"Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness","volume":"46","author":"Rajesh","year":"2023","journal-title":"Diabetes Care"},{"key":"R20-20250723","doi-asserted-by":"crossref","first-page":"AIoa2300030","DOI":"10.1056\/AIoa2300030","article-title":"Characterizing the clinical adoption of medical AI devices through U.S. insurance claims","volume":"1","author":"Wu","year":"2024","journal-title":"NEJM AI"},{"key":"R37-20250723","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41746-022-00621-w","article-title":"A reimbursement framework for artificial intelligence in healthcare","volume":"5","author":"Abr\u00e0moff","year":"2022","journal-title":"NPJ Digit Med"},{"key":"R38-20250723","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41746-022-00609-6","article-title":"Paying for artificial intelligence in medicine","volume":"5","author":"Parikh","year":"2022","journal-title":"NPJ Digit Med"},{"key":"R24-20250723","doi-asserted-by":"crossref","DOI":"10.1056\/AIpc2400083","article-title":"Scaling adoption of medical AI\u2014reimbursement from value-based care and fee-for-service perspectives","volume":"1","author":"Abramoff","year":"2024","journal-title":"NEJM AI"},{"key":"R21-20250723","first-page":"29","article-title":"Eye conditions in older adults: diabetic retinopathy","volume":"445","author":"Kirsch","year":"2016","journal-title":"FP Essent"},{"key":"R27-20250723","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/healthcare12020125","article-title":"Transformative potential of AI in healthcare: definitions, applications, and navigating the ethical landscape and public perspectives","volume":"12","author":"Bekbolatova","year":"2024","journal-title":"Healthcare (Basel)"},{"key":"R23-20250723","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41467-023-44676-z","article-title":"Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial","volume":"15","author":"Wolf","year":"2024","journal-title":"Nat Commun"},{"key":"R25-20250723","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1742-1241.2008.01921.x","article-title":"Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate?","volume":"63","author":"Baeza","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R26-20250723","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.7861\/fhj.2021-0095","article-title":"Artificial intelligence in healthcare: transforming the practice of medicine","volume":"8","author":"Bajwa","year":"2021","journal-title":"Future Healthc J"},{"key":"R33-20250723","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/healthcare9070835","article-title":"The rising burden of diabetes-related blindness: a case for integration of primary eye care into primary health care in Eswatini","volume":"9","author":"Maseko","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"R22-20250723","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/cd23-0019","article-title":"Clinical implementation of autonomous artificial intelligence systems for diabetic eye exams: considerations for success","volume":"42","author":"Wolf","year":"2024","journal-title":"Clin Diabetes"},{"key":"R32-20250723","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.oret.2020.06.016","article-title":"Diabetic retinopathy screening with automated retinal image analysis in a primary care setting improves adherence to ophthalmic care","volume":"5","author":"Liu","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R28-20250723","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13012-018-0784-z","article-title":"Engaging patients to improve quality of care: a systematic review","volume":"13","author":"Bombard","year":"2018","journal-title":"Implement Sci"},{"key":"R30-20250723","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12875-021-01493-x","article-title":"Effects of continuity of care on health outcomes among patients with diabetes mellitus and\/or hypertension: a systematic review","volume":"22","author":"Chan","year":"2021","journal-title":"BMC Fam Pract"},{"key":"R36-20250723","doi-asserted-by":"crossref","first-page":"1198228","DOI":"10.3389\/fmed.2023.1198228","article-title":"Planning an artificial intelligence diabetic retinopathy screening program: a human-centered design approach","volume":"10","author":"Scanzera","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R29-20250723","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1097\/pq9.0000000000000679","article-title":"Quality improvement to eliminate disparities in developmental screening for patients needing interpreters","volume":"8","author":"Brown","year":"2023","journal-title":"Pediatr Qual Saf"},{"key":"R35-20250723","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.eye.6702611","article-title":"Can we predict which patients are at risk of having an ungradable digital image for screening for diabetic retinopathy?","volume":"22","author":"Murgatroyd","year":"2008","journal-title":"Eye (Lond)."},{"key":"R34-20250723","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2146\/ajhp050064","article-title":"Health disparities: a barrier to high-quality care","volume":"62","author":"Mullins","year":"2005","journal-title":"Am J Health Syst Pharm"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T02:00:35Z","timestamp":1753236035000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004499","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}